Press release: STADA continues strong growth journey in the first half of 2024
One document
more
Stories about Biosimilar
- Language:
- Media:
- Period:
- Period:Total
Press release: STADA continues with double-digit sales and profit growth in 2023
One documentmoreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
more- 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
One documentmore
1